Skip to main content
OpenTrials

Clinical trial condition

Hypertension, Pulmonary

Explore clinical trials studying Hypertension, Pulmonary. Study availability and eligibility vary by location and protocol.

411 public trials 61 recruiting studies
Refine in advanced search Browse all conditions

Hypertension, Pulmonary trial results

Completed

Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects

NCT00741819

Conditions
Hypertension, Pulmonary, Lung Diseases, Pathologic Processes, +5 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • UCSD Medical Center La Jolla, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • Kansas University Medical Center Kansas City, Kansas, United States
View all 15 locations
View Trial Details
Completed

A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)

NCT00578786

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Sanatorio Otamendi Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Hospital Britanico-Buenos Aires Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Instituto del Corazon Denton A. Cooley Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • UAI Hosp. Universitario Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
View all 22 locations
View Trial Details
Completed

Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401

NCT01105117

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of California - San Diego La Jolla, California, United States
  • University of Colorado - Denver Aurora, Colorado, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • University of Pennsylvania-Penn Presybyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

NCT00617305

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Arizona Pulmonary Specialists Phoenix, Arizona, United States
  • West Los Angeles Healthcare Center Los Angeles, California, United States
  • Harbor - UCLA Torrance, California, United States
View all 30 locations
View Trial Details

Related conditions